Burning Rock Biotech (BNR) Competitors $8.71 +0.41 (+4.94%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$9.34 +0.63 (+7.28%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. TOI, LFMD, VMD, XGN, DCGO, CORBF, SERA, QIPT, BDSX, and ATPCShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Biodesix (BDSX), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Its Competitors Oncology Institute LifeMD Viemed Healthcare Exagen DocGo Global Cord Blood Sera Prognostics Quipt Home Medical Biodesix Agape ATP Oncology Institute (NASDAQ:TOI) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Do insiders & institutionals hold more shares of TOI or BNR? 36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, TOI or BNR? Oncology Institute has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Do analysts prefer TOI or BNR? Oncology Institute currently has a consensus price target of $7.00, indicating a potential upside of 124.36%. Given Oncology Institute's stronger consensus rating and higher probable upside, equities research analysts clearly believe Oncology Institute is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to TOI or BNR? In the previous week, Burning Rock Biotech had 1 more articles in the media than Oncology Institute. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for Oncology Institute. Oncology Institute's average media sentiment score of 1.33 beat Burning Rock Biotech's score of -0.05 indicating that Oncology Institute is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has stronger valuation and earnings, TOI or BNR? Burning Rock Biotech has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$393.41M0.74-$64.66M-$0.68-4.59Burning Rock Biotech$536.30M0.17-$47.49M-$1.90-4.58 Is TOI or BNR more profitable? Oncology Institute has a net margin of -14.26% compared to Burning Rock Biotech's net margin of -26.04%. Burning Rock Biotech's return on equity of -23.61% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-14.26% -1,527.21% -34.25% Burning Rock Biotech -26.04%-23.61%-15.73% SummaryOncology Institute beats Burning Rock Biotech on 9 of the 17 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$89.32M$2.93B$26.38B$10.17BDividend YieldN/A1.59%2.75%4.61%P/E Ratio-4.5824.3826.9326.39Price / Sales0.1763.051,210.48190.24Price / CashN/A41.6225.8729.91Price / Book1.187.957.706.28Net Income-$47.49M$34.73M$199.11M$270.38M7 Day Performance-6.75%6.41%3.47%1.89%1 Month Performance16.44%14.61%20.19%6.01%1 Year Performance143.98%58.90%49.63%25.26% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.8598 of 5 stars$8.71+4.9%N/A+144.0%$89.32M$536.30M-4.581,390Gap UpTOIOncology Institute2.8058 of 5 stars$3.25-1.5%$7.00+115.4%+847.8%$308.57M$393.41M-4.78660Positive NewsLFMDLifeMD3.5536 of 5 stars$6.15+1.5%$13.17+114.1%+10.6%$287.35M$212.45M-29.29230VMDViemed Healthcare2.6391 of 5 stars$6.87-0.1%N/A-10.9%$266.85M$224.26M20.211,179Positive NewsXGNExagen4.5494 of 5 stars$9.81+1.4%$11.25+14.7%+214.5%$212.77M$55.64M-11.02220Positive NewsAnalyst RevisionDCGODocGo2.3364 of 5 stars$1.57-0.6%$3.59+128.7%-57.3%$154.54M$616.55M-8.264,407Positive NewsCORBFGlobal Cord BloodN/A$1.05flatN/A-33.3%$127.63M$196.12M0.001,200Gap DownSERASera Prognostics1.4684 of 5 stars$3.17-5.1%N/A-59.5%$125.83M$80K-3.73120QIPTQuipt Home Medical1.9907 of 5 stars$2.58-0.4%$3.15+22.1%-5.7%$112.52M$245.91M-10.751,200Positive NewsBDSXBiodesix3.3883 of 5 stars$0.43-2.1%$1.75+304.9%-78.5%$64.72M$71.32M-1.49220News CoverageAnalyst UpgradeStock SplitGap DownATPCAgape ATP0.8119 of 5 stars$1.30+0.8%N/A-26.9%$64.51M$1.32M-3.1740Positive NewsGap Up Related Companies and Tools Related Companies Oncology Institute Competitors LifeMD Competitors Viemed Healthcare Competitors Exagen Competitors DocGo Competitors Global Cord Blood Competitors Sera Prognostics Competitors Quipt Home Medical Competitors Biodesix Competitors Agape ATP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNR Stock Alerts